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ABSTRACT 
Imaging is the key to diagnosing and guiding management of bone tumors.  Although 
radiographs are the gold standard for initial imaging evaluation and may make the 
diagnosis, computed tomography (CT) and magnetic resonance (MR) imaging are 
important adjunct tools for further characterization as a benign or aggressive lesion, 
accurately determining matrix composition, assessing lesion extent as well as secondary 
involvement of nearby structures if malignant, and staging tumors when applicable. In 
this article, we will highlight important features of CT and MR imaging for bone tumor 
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evaluation and review the cross-sectional imaging features of a broad spectrum of benign 
and malignant bone tumors. 
 
INTRODUCTION 
Malignant primary bone tumors make up only 0.2% of all malignancies in adults 
1,2
 and 
5% in children from ages 5-15 years old.
1,3
 Benign bone tumors are more common, but 
the true prevalence is unknown because they are often asymptomatic and go 
undiscovered. The clinical presentation of bone tumors can be challenging.  The 
nonspecific gradual onset of pain and swelling in most malignant tumors and 
asymptomatic nature of many benign tumors
1,4
 reinforces the importance of the 
radiologist’s role in detecting, working up, and staging bone lesions. It is important for 
radiologists to recognize imaging features that can distinguish non-aggressive incidental 
tumors from those that are aggressive or potentially malignant. In some cases, a specific 
diagnosis may be rendered based on patient age, lesion location, and recognition of 
characteristic imaging features. In other cases, a short list of the most likely differential 
diagnoses can be provided to help guide further workup and management.   
 
Furthermore, imaging plays a central role in the staging of malignant bone tumors. For 
over 30 years, a bone tumor-specific system by Enneking, et al, has been used
5
. While 
this is still used by some orthopedists and extensively used in the radiology literature, the 
recent focus on multidisciplinary team-based care has resulted in a shift to use the 
American Joint Commission on Cancer (AJCC) system.  Both classifications are 
discussed in a review by Balach and colleagues.
4
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 IMAGING 
Given the importance of imaging in bone tumor evaluation, the radiologist should be 
involved early on to help guide the most appropriate imaging technique(s). Key imaging 
information for the orthopedist includes the following: the character of the lesion (benign 
or aggressive), size and location of the lesion (including in relation to clinical landmarks), 
involved compartments, presence of skip metastases, relationship to neurovascular 
structures, intra-articular extension, and potential for imaging-guided needle biopsy.
6
 
 
Radiography 
Radiographs are the gold standard and first line imaging for tumor evaluation.
7
  The 
radiographic appearance indicates the lesion aggressiveness and establishes the 
differential and/or diagnosis.
8
 Key radiographic features include the location, margins, 
matrix, periosteal reaction, and general aggressiveness of the lesion.
9,10
 From the patient 
history, age, lesion location, and radiographic appearance, 80% of bone lesions may be 
correctly identified.
6
  In appropriate cases, cross sectional imaging further characterizes 
the lesion, and in cases of aggressive or malignant disease is critical to determine extent 
of disease and stage the tumor.  This information has revolutionized surgical treatment, 
enabling limb salvage, which was nonexistent 30 years ago.
11
   
 
Computed Tomography 
Depending on the radiographic appearance and differential diagnosis, CT or MR imaging 
are the next best imaging techniques according to the ACR Appropriateness Criteria.
7
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High spatial resolution CT provides exquisite detail of cortical and trabecular bone, 
making it an important tool in a variety of cases and specific tumors.  For example, CT is 
the exam of choice for specific diagnoses, such as osteoid osteoma.
1
 CT is better than 
MR imaging at evaluating cortical involvement, destruction, or breakthrough; matrix 
mineralization; and periosteal reaction.
9–12
 Structural integrity or risk of impending 
pathologic fractures may also be inferred by evaluation of cortical involvement,
4
 and 3D 
reconstructions can be helpful evaluating surface lesions.
12
 Further, lesions in complex or 
flat bones, such as the pelvis, spine, scapula, and ribs, are often poorly visualized on 
radiographs, making CT the imaging technique of choice for such bones.
4,9,11,12
    
 
CT imaging of bone lesions is performed with thin collimation and high detail technique. 
Thin section axial, coronal, and sagittal multiplanar reformations are created, typically 
using a bone filter, though additional axial reformatted images with a soft tissue filter 
may also be created to better assess soft tissue components or intramuscular extension. 
Intravenous contrast media may be useful in assessing non-osseous soft tissue 
components of the tumor.  
 
Magnetic Resonance Imaging 
The superior soft tissue contrast of MR imaging makes it often the most appropriate study 
to evaluate a bone tumor after radiography.
7
 Details of the intramedullary and 
extraosseous extent of a tumor, presence of an associated soft tissue mass, and 
involvement of adjacent structures, including neurovascular bundles, intra-articular 
space, and muscle or adjacent fat planes, are best seen with MR.
1,4,9,10,12,13
 According to 
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multiple studies, MR imaging was superior to CT in assessing bone marrow involvement 
(33-38%) and soft tissue tumor extent (38-54%), as well as neurovascular (69%) and joint 
involvement (100%).
10,14
 Intratumoral necrosis versus viable tissue may also be 
delineated on MR imaging, which aids in biopsy planning. For these many reasons, MR 
imaging plays a crucial role in staging musculoskeletal lesions and planning for 
appropriate limb salvage when applicable.
11
  
 
The imaging characteristics of tumors will be discussed individually below.  However, 
neurovascular bundle involvement is characterized by soft tissue surrounding at least 180 
degrees of the bundle (best seen on axial images), and joint involvement is defined by 
disruption of the joint capsule or articular subchondral bone plate/cartilage on T1 
images.
10
 
 
The mainstay of MR imaging of tumors is multiple orthogonal spin echo T1- and T2-
weighted sequences.  The soft tissue contrast and ability to differentiate tissue 
compositions is due to the different and adaptable imaging parameters and sequences. 
Evaluation of tumors should include at least one large field-of-view (FOV) sequence to 
survey the entire bone for tumor extent and skip metastases.  A large FOV sacrifices 
spatial resolution, however, so a small FOV and surface coil should be used for the 
remainder of the exam to ensure the best resolution possible.
4,6
 At our institution, tumor 
MR imaging protocols include T1, T2 fat-suppressed (T2FS) or short tau inversion 
recovery (STIR), and post-contrast T1 fat-suppressed (T1FS+C) sequences in axial, 
coronal, and sagittal planes. The added time for all three planes (rather than just two 
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planes) may be warranted due to the uncertainty of the best imaging orientation with 
respect to the lesion.
15
 Chemical shift imaging with in- and out-of-phase gradient echo 
sequences may be added to an examination for problem solving, where lack of out-of-
phase signal dropout indicates marrow fat replacement.
16,17
  
 
Advanced Imaging 
Advanced imaging is beyond the scope of this article but includes advanced MR 
techniques and positron emission tomography (PET)-CT.  MR dynamic contrast 
enhancement has demonstrated promise delineating between viable tumor (rapid 
enhancement) versus posttreatment change (slow enhancement).
1,18
 MR spectroscopy and 
diffusion imaging are also being studied for their utility in identification of benign versus 
malignant bone lesions, as well as differentiation between tumor and peritumoral edema, 
both after chemotherapy and surgery.
4,15,16
 Lastly, PET-CT, the gold standard in 
metabolic imaging, has been extensively studied as a problem-solving tool in sarcoma 
imaging and is most often used to help determine the most active regions for biopsy 
planning, to detect metastatic disease, and to evaluate posttreatment response.
4,15,16
 
Unfortunately, there is significant overlap in SUV measurements for benign and 
malignant bone lesions, thus there is limited utility in determining the underlying etiology 
of a bone lesion with PET imaging. 
 
BONE TUMORS 
There are many ways to group and differentiate tumors, including by location,
19
 age,
9
 cell 
type,
1
 and imaging appearance. The World Health Organization classifies bone tumors by 
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origin of cell type. We will modify this approach and use the tissue composition or 
matrix, a consequence of the cell origin, to work through a differential list of select bone 
tumors, highlighting the appearances on CT and MR imaging.   
 
Osteoid tumors 
Osteoid tumors range from benign osteoid osteomas and osteoblastomas to a spectrum of 
various osteosarcomas.  These bone-forming lesions have distinct osteoid composition, 
often with characteristic mineralization pattern, to help differentiate from tumor of other 
compositions and histologic origins.   
 
Osteoid osteomas comprise 10% of all benign bone tumors, and are usually found in 
young patients (5-30 years).
20
 They frequently occur in long bones (>50% in tibia and 
femur), spine (90% in posterior elements), and feet with hallmark symptoms of dull 
aching pain that is worse at night and relieved by salicylates.
20–22
 Spine lesions may 
present with new-onset painful scoliosis.
20–22
  
 
Histologically, osteoid osteomas are a small (1mm - 2cm) nidus of richly innervated 
osteoid and woven bone on a background of vascularized fibrous connective tissue.
20,21
 
The nidus is radiolucent with variable mineralization, which may be evident 
radiographically but is better seen with CT, the imaging method of choice because of the 
spatial resolution. Intracortical osteoid osteomas (70%) cause reactive cortical thickening 
and benign periosteal new bone formation around the radiolucent nidus, which are also 
best assessed on CT (Fig. 1).
20,22
 When located in medullary, subperiosteal, or intra-
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articular locations, sclerosis and periostitits are less common, making nidus identification 
by CT the key to the appropriate diagnosis.
20
 Subperiosteal osteoid osteomas, classically 
at the femoral neck, may demonstrate the nidus with shallow scalloping of the underlying 
cortex. Intra-articular lesions are also difficult to diagnose, sometimes only demonstrating 
secondary signs of a reactive joint effusion, synovitis, or periarticular osteopenia.
21
  
 
MR imaging of osteoid osteomas is variable and may show nonspecific findings, 
particularly if the nidus is not recognized as has been reported in up to 35% of cases due 
to poor evaluation of cortical bone and thick slices.
20,23
 When visible, the nidus is low to 
intermediate signal on T1 and intermediate to high signal on T2 weighted images.  
Because of the vascularized stroma, the nidus does often enhance, though reactive 
surrounding edema may also enhance
20,21
 Internal matrix calcifications are low signal but 
often too small to be accurately visualized. Reactive bone and soft tissue edema is 
consistently visualized (Fig. 1) but is not adequate to accurately diagnose this lesion.
23
 
 
Osteoblastomas share the same histology as osteoid osteomas, but are a less common 
tumor. They also typically occur in patients <30 years old and are differentiated from 
osteoid osteomas by size, where the nidus of an osteoblastoma is >2 cm.
20,21,24
 Unlike 
osteoid osteomas, these lesions produce dull pain and soft tissue swelling (not night 
pain)
20,25
 and are more commonly found in the axial skeleton, including the posterior 
elements of the spine (35-40%) and sacrum (up to 40%), followed by long bone 
diaphyses (30%).
20,21,26
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CT is also the imaging method of choice because it best characterizes the matrix 
mineralization, as well as the integrity of the cortex.
20
 Generally there is a round or oval 
radiolucent, well-circumscribed, expansile lesion, measuring >2 cm, with at least partly 
calcified matrix (Fig. 2).  Compared with osteoid osteomas, there tends to be less reactive 
sclerosis but more periosteal reaction and more aggressive features like bone destruction 
and soft tissue infiltration.
25–27
 
 
MR imaging features of osteoblastoma are also nonspecific, though are useful to define 
the extent of osseous involvement and possible extraosseous soft tissue extension, 
particularly within the spinal canal.
20,21
 Osteoblastomas tend to have a sharply 
demarcated nidus of low to intermediate signal on T1 and intermediate to high signal on 
T2 weighted images when nonmineralized, as well as areas of low signal intensity on all 
sequences when mineralized. These tumors can also demonstrate substantial intraosseous 
and surrounding soft tissue inflammation (Fig. 2).
20,21
 
 
Osteosarcomas are the second most common primary malignancy of bone, following 
myeloma.
21,28
 They may be primarily osteoblastic (50-80%), chondroblastic (5-25%), or 
fibroblastic (7-25%),
29,30
 and  can be divided by differences in cell type, histologic grade, 
or location in bone into the following: high-grade intramedullary (conventional) 
osteosarcoma (75%), telangiectatic (4-11%), surface osteosarcomas (4-10%,), small cell 
(1%), intra-osseous low-grade (<1%), maxillofacial or gnathic (1%), and secondary 
osteosarcoma (5-7%).
21,28,30
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Conventional osteosarcoma is a high-grade intramedullary tumor with peak incidence in 
the 2
nd
 or 3
rd
 decades.
28,30
 They usually occur in long tubular bones (70-80%), nearly 
always in the metaphysis (90-95%), particularly about the knee where 35-45% of cases 
involve the distal femur and 15-20% the proximal tibia.
28,29
 Clinically, patients present 
with pain and swelling and may have limited range of motion of the nearest affected 
joint. The diagnosis is often suggested by its typical radiographic appearance, including a 
large mixed lytic and sclerotic lesion with cortical destruction, ill-defined margins, 
aggressive periosteal reaction (laminated, hair-on-end, Codman triangle, or sunburst 
patterns), a soft tissue mass, and fluffy or cloud-like osteoid matrix.
12,28,31
 
CT is helpful identifying osteoid production which may be subtle and only visible by CT 
in some tumors.
31
 It can also provide a more complete assessment of classic features, 
including cortical destruction and periosteal reaction (Fig 3). The non-mineralized intra-
osseous components are more challenging to characterize on CT though replace the 
normal low attenuation medullary fat with soft tissue density.  Areas of necrosis within 
the tumor are low attenuation but still higher than fat density.
21,28
 
 
MR imaging is the imaging of choice for staging and assessment of the extent of the 
tumor, including epiphyseal involvement, presence of skip metastases, extraosseous soft 
tissue invasion, intra-articular spread, and relationship to surrounding structures.
21
 These 
tumors are most commonly low signal on T1 and high signal on T2 weighted images, 
replacing the normal marrow fat and extending into the adjacent soft tissues through 
areas of cortical destruction (Fig. 3). Heterogeneous signal is seen in areas of internal 
hemorrhage and necrosis.
31
 Mineralized matrix, dark on all sequences, may be 
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overlooked or difficult to identify on MR imaging.  However, edema and soft tissue 
characterization are readily seen with fat-suppressed T2 and postcontrast T1 sequences.  
The extent of peritumoral edema is important and must be reported for appropriate 
surgical resection, ensuring removal of potential underlying viable tumor cell nests.
21
 
Contrast enhancement also helps identify viable tumor, which affects both pre- and post-
treatment staging.
9
 
 
The next most common osteosarcoma is telangiectatic osteosarcoma. This aggressive 
variant makes up 4-11% of osteosarcomas and has similar demographic features as 
conventional osteosarcoma, including mean age, location (most commonly at the knee 
and generally metaphyseal in long bones), and frequent epiphyseal extension.
28,32,33
 
Differentiating features include the more common presentation with pathologic fracture 
(up to 60%) and the characteristic imaging appearance.
21,32
 
 
By definition, telangiectatic osteosarcoma must have hemorrhagic, cystic, or necrotic 
spaces, lined by malignant cells, that occupy more than 90% of the lesion before 
treatment.
21,28
 The tumor-lined blood-filled cystic spaces demonstrate characteristic fluid-
fluid levels (74-90%), as well as aggressive features of osseous expansion, osseous 
destruction, aggressive periosteal reaction, and matrix mineralization.
28,30,32
 The fluid-
fluid levels may be confused for benign lesions, namely aneurysmal bone cysts (ABCs), 
so careful attention to differentiating features, such as peripheral nodularity and extension 
into the surrounding soft tissues, should be made on CT and MR imaging. 
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CT is superior at delineating the osseous expansion of the cortex, areas of cortical 
destruction, pathologic fracture, aggressive periosteal reaction patterns, and matrix 
mineralization. The latter is an important distinguishing feature from ABCs and is present 
in up to 58% of cases but nearly always mild, which may be missed on MR imaging in up 
to 52% of cases.
21,30,32
  The cystic spaces demonstrate nonspecific low CT attenuation but 
heterogeneous fluid signal on MR imaging often with classic fluid-fluid levels from 
layering hemorrhagic contents. Peripheral nodular soft tissue tumor, also an important 
distinguishing feature from ABCs, is higher attenuation (similar to muscle) on CT, 
intermediate to high T1 signal on MR imaging, and enhances after contrast 
administration on both image techniques.
28,32
 Extent of intramedullary disease, presence 
of cortical destruction with a soft tissue mass (seen in 89% of cases), and identification of 
joint involvement (44%) and neurovascular encasement (26%) are best seen on MR 
imaging.
32
   
 
Surface osteosarcomas are another subset of osteosarcoma, making up 4-10% of all 
osteosarcomas. This group includes intracortical, high grade surface, periosteal, and 
parosteal osteosarcomas, which vary widely in appearance.  
 
Periosteal osteosarcomas make up 25% of surface osteosarcomas.
28,30
 They are highly 
chondroblastic and frequently non-mineralized, and arise from the deep periosteal 
surface, typically from a long bone diaphysis, where they tend to produce periosteal 
reaction perpendicular to the cortex, cortical thickening, and cortical scalloping or saucer-
like erosion underlying a broad based surface soft tissue mass that demonstrates high 
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water content low density on CT and high signal on T2 weighted MR images (Fig. 
4).
21,30,34
 Unlike parosteal osteosarcomas, intramedullary extension is uncommon and 
high T2 intramedullary signal on MR imaging represents reactive changes, particularly 
when not contiguous with the mass.
30,34
 
 
Finally, parosteal osteosarcomas are the commonest of the surface osteosarcomas, 
comprising 65% of these surface malignancies,
21
 and are low-grade tumors growing from 
the outer layer of the periosteum.
30,35,36
 Though commonly cited to occur in skeletally 
mature patients, a review of more than 200 cases by Okada, et al, demonstrated a mean 
age of 13 years, ranging from 2-41 years.
36
 Despite being low-grade tumors, higher grade 
features may be seen, including osteoblastic intramedullary invasion in up to 22-50%
35,36
  
and unmineralized soft tissue at the periphery of the mass in 32% with soft tissue and/or 
neurovascular invasion in a subset of these cases (Fig. 5).
36
 These are best characterized 
on imaging as an exophytic, cauliflower-like mass with dense central mineralization and 
a small connecting stalk to the underlying bone, best seen with CT.
9,21
 Intraosseous 
extension, typically osteoblastic (not lytic) is also best identified by CT and may indicate 
a higher grade tumor.
35
 Other signs of higher grade disease include regions of 
unmineralized soft tissue or a discrete soft tissue mass, particularly when at the periphery 
of the tumor and if measures more than 1 cm
3
.
28,35,36
 The presence of a soft tissue mass, 
while usually visible on CT, is more avidly identified and characterized on MR imaging, 
where the mass most commonly demonstrates high signal on T2 weighted images.
35
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Chondroid Tumors 
Chondroid matrix tumors range from benign tumors, including chondroblastomas, 
chondromyxoid fibromas, and enchondromas, to malignant tumors, primarily a spectrum 
of chondrosarcomas.   
 
Chondroblastoma is a rare, benign chondroid tumor (<1% of primary bone tumors) that 
typically occurs in the epiphysis, or epiphyseal-equivalents, of skeletally immature 
patients in their 2
nd
 decade.
12,37,38
 Characteristically located in the epiphyses of long 
bones (75-80%), these tumors are mostly found in the proximal tibia (25%), distal femur 
(24%), proximal humerus (23%), and proximal femur (22%), with most others occurring, 
in the small bones of the feet (talus, calcaneus, and cuboid) or patella.
12,38
 Unlike most 
benign bone lesions, these tumors present with pain in nearly all cases.
38,39
 
 
Radiologically, this tumor presents as a well-defined geographic lytic lesion with 
lobulated contour eccentrically located in the epiphysis.
12,37,38,40
 These tumors may 
demonstrate a thin sclerotic border and, in up to 30%, scattered matrix mineralization 
38,40
, both of which may be radiographically occult and are best seen by CT (Fig. 6). More 
than half of chondroblastomas demonstrate a nearly pathognomonic pattern of thick, solid 
periosteal reaction at the metaphysis, distant from the epiphyseal lesion, which is also 
best seen on CT.
38–41
 Active periostitis, on the other hand, may be better seen on MR 
imaging. In a study by Weatherall and colleagues, only 11 of 22 lesions demonstrated 
periosteal reaction on CT, but 17 or 22 demonstrated periosteal reaction or edema on MR 
imaging.  
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 Other important MR imaging features include a well-defined, lobular epiphyseal lesion 
with intermediate to high signal on T2 weighted images and extensive perilesional bone 
marrow and soft tissue edema.
38–42
 Although there is a classic chondroid lobular contour, 
the signal on T2 images may not be the water-bright signal seen with most chondroid 
lesions due to abundant immature matrix and hypercellular chondroblasts (Fig. 6).
38
 This 
appearance, if not recognized, may be mistaken for tumors of other compositions, such as 
osteoblastomas, fibroxanthomas, or giant cell tumors.
40
 The perilesional edema (77-100% 
of cases) is a hallmark of this tumor but can be confused for an inflammatory or 
infectious processes, such as a Brodie’s abscess.12,39,40 This edema resolves after surgical 
treatment and can be a helpful sign for tumor recurrence on follow-up imaging.
37
 
 
Chondromyxoid fibroma (CMF) is an even rarer benign chondroid tumor (0.004% of 
primary bone tumors) typically occurring in young patients (1
st
-3
rd
 decades) and may 
present with pain and swelling.
12,38
 Although benign, this tumor may be considered 
aggressive with high recurrence rate after curettage.
43–45
 The tumor is composed of 
variable quantities of chondroid, myxoid, and fibrous tissues, making the imaging 
appearance variable and the pathologic diagnosis difficult. Radiologically, CMFs are 
circumscribed lytic lesions with a narrow zone of transition, sclerotic rim, and scalloped 
or expanded overlying cortex (Fig. 7). They are typically located eccentrically in the 
metaphyses of lower extremity long bones (75% of cases), most commonly in the 
proximal tibia.
12,43–46
 CT occasionally demonstrates internal calcified matrix (~15%)
38
.  
The typical cartilage composition is best seen on MR imaging with intermediate to low 
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signal on T1 and high signal on T2 weighted images with variable homogeneity based on 
quantities of chondroid and myxoid tissue in the tumor (Fig. 7).
12,43,45
  Periosteal reaction, 
although rare with these lesions, was also noted by Kim, et al, to have a higher 
prevalence on MR imaging.
43
  
 
Enchondromas are common benign intramedullary hyaline cartilage tumors (12-24% of 
benign bone tumors), typically asymptomatic and discovered incidentally in nearly any 
age group (more often in the 2
nd
-4
th
 decades).
9,37,47–50
 They are most commonly found in 
the small bones of the hands (28-60% of cases), followed by the metaphysis or epiphyses 
of long bones (25%),
38,47–49
 and demonstrate the signature appearance of cartilage lesions: 
a lobular lesion with water density/intensity (due to high water content of cartilage) and 
variable degrees of internal ring-and-arc mineralized matrix.
9,38,42
 When eccentric, 
endosteal scalloping may also be seen,
9,49,50
 but cortical destruction, periosteal reaction, 
and a soft tissue mass should not be present and suggest a malignant chondroid lesion.  
 
CT is best for confirming “ring-and-arc” matrix mineralization and evaluating endosteal 
scalloping of enchondromas (Fig. 8). “Ring-and-arc” mineralization is usually present in 
some quanitity (~95%) except for the small bones of the hands and feet where it is rather 
uncommon.
38,47,49,51
 Endosteal scalloping is seen in up to 70-100% of enchondromas 
depending on the lesion location and is also best seen on CT.
49,50
 In a study of 133 
cartilage lesions by Santacreu, CT showed twice as many cases (64%) actually involved 
the cortex compared to only 32% on MR imaging.
52
 Murphey and colleagues 
demonstrated a correlation with malignancy when there is deep endosteal scalloping 
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(>2/3 the normal cortical thickness).
48
 However, if the lesion is eccentric, located in small 
bones, or an isolated finding, deep scalloping does not necessarily indicate 
malignancy.
49,50
 
 
MR imaging is the method of choice to demonstrate the signature cartilage appearance of  
lobular high signal on T2 weighted images (Fig. 8), which is quite specific (79%) but not 
highly sensitive (35%) for cartilage.
38,42,49,53
 The addition of intravenous contrast images 
with ring-and-arc enhancement increases the sensitivity for cartilage lesions up to 83%.
42
 
 
One of the greatest challenges in assessing enchondromas is distinguishing it from a 
chondrosarcoma (CS), particularly in long bones.
38,48,50,52,54
 Similar to osteosarcomas, 
there are a number of subtypes of chondrosarcomas, though we will focus on the 
conventional or central chondrosarcoma as it is by far the most common type.   
 
Chondrosarcomas are the third most common primary bone tumor (8-17% of bone 
tumors) and usually present in the 5
th
 and 6
th
 decades, arising de novo (primary) or from a 
pre-existing lesion such as the cartilage cap of an osteochondroma or from an 
enchondroma.
37,55,55–57
 They usually occur in the metaphyses of long bones (45%), 
particularly the femur, humerus, and tibia, but they may also be diaphyseal (36%), 
epiphyseal (16%), or in the axial skeleton where the ilium followed by ribs, scapula, and 
sternum are more commonly involved.
57
  In general, chondrosarcomas are typically large 
in size (>5 cm) and cause pain, which are important differentiating features from 
enchondromas (usually <4cm and asymptomatic).
48,52
  However, the clinical, imaging, 
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and pathologic distinction between cellular enchondromas and low grade 
chondrosarcomas can be extremely difficult.
37,51,54,55
 
 
Low grade chondrosarcomas demonstrate signature cartilage features commonly similar 
to enchondromas, including ring-and-arc mineralization in up to 60-78% of cases (Fig. 
9).
57
 However, deep endosteal scalloping (described above), cortical remodeling with 
permeative or moth-eaten destruction (higher grade CSs), and especially an associated 
soft tissue mass are distinguishing features of chondrosarcomas (Figs. 9 & 10).
37,48,57
  The 
first two of these characteristics are best delineated on CT, while the latter is best 
determined with MR imaging.  Further, entrapment of the underlying native bone marrow 
fat is a hallmark feature of low grade CSs differentiating from enchondromas, which is 
seen as speckled areas of increased T1 signal on MR imaging in up to 35% of cases.
56,57
 
With higher grade CSs, soft tissue components are more prevalent and areas of trapped 
bone are less common.  Septal and rim enhancement may be seen with low grade CSs on 
both CT and MR imaging, whereas higher grade lesions may show diffuse enhancement 
due to greater soft tissue mass component and less well-differentiated cartilage.
42,51,55,57
 
 
Fibrous Tumors 
Fibrous lesions of bone encompass a wide spectrum of benign and malignant tumors or 
tumor-like conditions. The focus here will be lesions that manifest a recognizable fibrous 
matrix on imaging.     
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Fibrous dysplasia is the commonest of these and is a benign lesion of marrow 
replacement with fibrous tissue containing irregular spindles of largely non-mineralized 
woven bone.
58,59
 It can occur in nearly any bone, present at any age, and is usually  
monostotic (80%). When polyostotic (20%), it may be seen with various syndromes like 
McCune Albright and Mazabraud syndromes.
58,60
 
 
Radiologically, fibrous dyspasia is classically a lytic, expansile intramedullary lesion that 
may demonstrate smooth endosteal scalloping and deformities of long bones, such as the 
“shepherd’s crook” deformity of the proximal femur or “saber shin” deformity of the 
tibia.
58–60
 CT clearly identifies the typical “ground-glass,” hazy internal appearance of 
fibrous composition (usually 70-130 Hounsfield units (HU)) with or without a thin 
sclerotic rim (Fig. 11).
58,59
 The degree of ground-glass opacity ranges from nearly 
completely lytic to diffusely dense and correlates with the histologic degree of fibrous 
elements (more radiolucent) and woven bone (more radiopaque).
58
 
 
MR imaging is non-specific and the quite variable, typically hypointense on T1 but 
ranging from hypointense to hyperintense signal on T2 weighted images, depending on 
the proportions of fibrous tissue, mineralized trabeculae, and cystic or hemorrhagic 
degeneration (Fig. 11).
60–62
 Intravenous contrast enhancement is also variable and 
potentially confusing as the tissue is relatively vascular with numerous small vessels 
centrally and large peripheral sinusoids. Thus, they may demonstrate central contrast 
enhancement (majority) or peripheral enhancement.
62
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Osteofibrous dysplasia (OFD) is a rarer benign fibro-osseous neoplasm (0.2% of primary 
bone tumors) that typically occurs in the first decade of life and is characteristically found 
in the tibia (95% of cases).
63–66
 Synchronous fibular lesions are seen in up to 12%.
65,66
 
OFDs are self-limiting and undergo spontaneous regression in puberty
65
 but can overlap 
with the appearance of adamantinomas (AD), a malignant fibrous neoplasm that typically 
presents in adolescence.  
 
Histologically, OFDs are composed of osteoid, fibrous, and epidermoid tissue.
63,65
 
Radiologically, these lesions are classically well-defined intracortical expansile lytic 
lesions, which may be solitary, multilocular, or multifocal, with varying degrees of 
surrounding sclerosis in the anterior mid tibial diaphyseal cortex (Fig. 12).
66,67
 Ground-
glass mineralization typical of fibrous lesions is seen in approximately 40% of cases, 
notably more common than seen in ADs (25% of cases).
67
 CT is preferred over MR 
imaging for characterizing this lesion because it is best at identifying the intracortical 
location, ground-glass matrix, and intramedullary extension (40% of OFDs). Solid 
periosteal reaction, tibial bowing, and pathologic fractures are possible findings but not 
consistently seen.
65,67
 MR imaging is less helpful in making the diagnosis but more 
helpful in planning biopsy approach and surgical staging. There is usually intermediate 
signal on T1 and heterogeneously intermediate or, less commonly, high signal on T2 
weighted images, depending on the cellularity and mineralization (Fig. 12).
66
 A thick low 
intensity rim from the surrounding sclerosis may be seen. Diffuse enhancement is the 
most common pattern on postcontrast images due to rich fibrovascular stroma similar to 
other fibro-osseous lesions.
66
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 Adamantinoma is a rare low-grade malignant tumor (<0.5% of bone tumors) postulated 
by some to be in the same disease spectrum as OFD, presenting similarly in location 
(anterior tibial cortex) and radiologic characteristics.
66–68
 Adamantimoma, however, 
usually presents later (2
nd
 or 3
rd
 decade in up to 75% of cases) than OFD and with larger 
lesions (average 13 cm vs 6 cm) and more aggressive features than OFD on imaging, 
such as skip lesions (38%), “moth-eaten” (up to 88%) or destroyed cortex (38%), 
complete medullary involvement (67-88%), and extraooseus soft tissue extension (15%) 
(Fig. 13).
65–67
 
 
Other fibrous tumors of bone include benign entities such as desmoplastic fibromas and 
benign fibrous histiocytomas, as well as malignant lesions such as fibrosarcomas and 
malignant fibrous histiocytomas (MFH).  These tumors represent a range of non-
aggressive lytic to very aggressive destructive lesions of bone and have less specific 
imaging appearances, thus are only briefly mentioned here.  In general, fibrosarcomas 
and malignant fibrous histiocytoma (MFH) are indistinguishable by imaging and 
demonstrate geographic, moth-eaten, or permeative cortical destruction, commonly in 
long bones.
69,70
 CT is best for evaluating cortical destruction, and MR imaging is useful 
in determining intraosseous extent and soft tissue involvement.  
 
Vascular bone tumors 
Vascular lesions of bone also range in their histologic grade, of which the most 
commonly encountered lesion is the hemangioma.  Hemangiomas are benign, slow-
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growing vascular neoplasms composed of a mixture of vessels, fat, smooth muscle, 
fibrous tissue, and clotted blood.
71,72
 They are most commonly found in women in the 4
th
-
5
th
 decades, primarily in the spine. The classic CT appearance of spine lesions is 
diagnostic and includes a well-circumscribed hypodense lesion with a “corduroy” 
(coronal or sagittal plane) or “polka dot” (axial plane) appearance due to coarsened 
trabecula. The MR appearance of vertebral hemangiomas is dependent on the quantity of 
fatty stroma versus vascular elements, the former of which is more prevalent in classic 
lesions and produces hyperintensity on T1 that fat-suppresses. These lesions are 
hyperintense on T2 weighted images regardless of composition due to the vascular 
elements.   
 
The much rarer appendicular hemangioma is extremely varied in appearance. Generally, 
these lesions are well-defined, lobular lytic intramedullary lesions, though some appear 
aggressive with moth-eaten margins, an associated soft tissue component, and/or 
perilesional bone marrow and soft tissue edema.
71,72
 They may demonstrate coarsened 
trabeculae, a key to the imaging diagnosis, or internal mineralization, both of which are 
best seen on CT.
71,72
 Cortical thinning or erosion is seen on CT in 29% and 7% of cases, 
respectively.
71
 The MR appearance is strikingly different from vertebral lesions with iso- 
to hypointense signal on T1 images.  Hyperintensity on T2 and variable heterogeneous 
enhancement is typical but nonspecific.  The low signal intensity trabecular pattern is 
seen in only 42% on MR imaging and is better characterized with CT.
71
  Ultimately, 
because of their varied appearance, pathologic diagnosis is required.
72
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Malignant vascular tumors (MVT) of bone are also quite rare (<1% of primary malignant 
bones tumors) and demonstrate a varied and nonspecific appearance. This category of 
lesions includes low-grade hemangioendotheliomas and their epithelioid variants to high 
grade angiosarcomas.  They are more commonly found in lower extremity long bones 
and are always osteolytic, variably expansile, and often heterogeneous in density/signal 
with avid but heterogeneous enhancement, varying somewhat depending on grade of the 
tumor.
73
 An associated soft tissue mass and cortical destruction are common, but there is 
characteristically no periosteal reaction.
73,74
 CT best depicts the presence and degree of 
cortical destruction and reactive cortical sclerosis, whereas soft tissue extension and 
reactive change may be better identified on MR. MR features include ill-defined high 
signal on T2-weighted images and enhancement, extending into the surrounding bone and 
soft tissues, mostly due to reactive edema based on pathologic correlation.
73
  
 
Fat origin tumors 
Several of the tumors described to this point have had components of fat, including areas 
of trapped marrow fat in low-grade chondrosarcomas and fatty stroma of hemangiomas.  
However, bone tumors with fat composition or origin are another category of tumors for 
consideration when differentiating primary bone tumors on imaging.  
 
Intraosseous lipomas are the most common fat-containing primary bone tumor (<0.1% of 
all bone tumors). Although cited as very rare, the prevalence may be much greater by 
anectodal reports from Murphey and colleagues due to its incidental nature. These tumors 
are located in long bones, most commonly the femur (34%), and other characteristic 
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locations such as the calcaneus (8%) and ilium near the sacroiliac joint (8%).
75
  The 
radiographic appearance is nonspecific, but CT and MR are usually diagnostic with fat 
clearly visible by both techniques.
75,76
 CT demonstrates a circumscribed hypodense 
lesion, measuring -60 to -100 HU, with a thin calcified rim (Fig. 14)
75
.  MR imaging 
similarly demonstrates high signal on T1 and T2 weighted images, similar to 
subcutaneous fat, with signal loss on fat-suppressed sequences.
75,76
 Gradient echo 
imaging, where calcification displays bold hypointense signal, may also be helpful to 
delineate the calcified rim and a central calcified “scar”.76 Adjacent normal marrow fat 
has a slightly higher density on CT and slightly lower T1 signal on MR imaging due to 
cellular marrow elements.
75
 Evolution of these lesions, classified by Milgram and 
colleagues, results in signal changes, most notably central areas of ring-like or dystrophic 
“central scar” calcification with lesion maturation and fat necrosis.77 This appearance is 
essentially diagnostic of an intraosseous lipoma on CT and MR imaging.  At times, these 
lesions may be confused with osteonecrosis or chondroid lesions, but the generally 
rounded margins helps distinguish the lesion as a lipoma rather than either differential 
entity.
75,78
 
 
Another tumor to consider when analyzing a fat-containing lesion is a liposarcoma of 
bone, a primary bone malignancy arising from lipoblasts that follows a similar course as 
soft tissue liposarcomas.  These tumors are extremely rare with less than 100 reported in 
the literature. CT and MR imaging reveals predominantly fat-containing lesions but 
demonstrate aggressive features, including cortical erosion/destruction and an 
extraosseous extension of a soft tissue mass.
79
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 Round cell tumors 
The final group of tumors we will discuss includes a mix of tumors with common cellular 
and imaging features rather than cell origin or tissue composition.  These tumors 
(collectively round cell tumors) include myeloma, lymphoma, and Ewing sarcoma, and 
share the common histology of being highly cellular tumors composed of homogeneous 
undifferentiated, basophilic, cytoplasm-poor, round cells.
12
 
 
Myeloma, although arguably a marrow tumor, is considered the most common primary 
malignancy of bone,(27% of biopsied bone tumors).
12,37
 It can occur anywhere but 
classically affects the skull and axial skeleton, followed by the appendicular skeleton.  
Patients typically present at  >40 years with either local symptoms of pain/pathologic 
fractures or systemic marrow symptoms.
37
 
 
The variable imaging appearance results from cellular activation of osteoclasts and 
inhibition of osteoblasts by myeloma cells, resulting in bone destruction.
9,12
 There may be 
a solitary or multiple focal well-defined lytic lesions with a “punched out” appearance 
and nonsclerotic narrow or wide zone of transition (Fig. 15).  Although skeletal survey is 
still recommended as the gold standard for initial screening and staging, PET-CT and 
whole body MRI are more sensitive and increase the yield for detection of myeloma 
lesions.
80–82
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CT will reveal a focal lytic lesion without internal matrix, and internal soft tissue density 
helps differentiate from other lytic etiologies, such as a bone cyst or fibrous dysplasia. 
More sensitive than CT or radiographs, MR imaging demonstrates one of the following 
four patterns: normal bone marrow, a micronodular (salt-and-pepper) appearance, a focal 
lesion, or diffuse marrow abnormality.
80,83
 A typical myeloma lesion demonstrates 
hypointense T1 signal, homogeneous hyperintense T2 signal, and diffuse contrast 
enhancement (Fig. 15).
9,12,37
 These lesions are typically round, central intramedullary 
lesions, though endosteal or full thickness cortical erosion may be seen.  Cortical 
breakthrough and soft tissue extension are not uncommon and are particularly well 
characterized by MR imaging.
37
 Diffuse disease, also detected best by MR imaging, may 
demonstrate diffuse heterogeneous signal with innumerable areas of the signal described 
above.   
 
Primary lymphoma of bone is another small round cell tumor in the differential diagnosis 
of myeloma, and is defined as lymphoma affecting one or multiple bones, generally 
without lymph node involvement. This form of lymphoma is uncommon (3-5% of 
malignant bone tumors and 4-5% of extranodal lymphomas)
9,12,84
 and typically present in 
the 4
th
-6
th
 decade with a painful soft tissue mass or systemic symptoms.
12,37,84
 These 
tumors are most commonly found in the metadiaphysis of long bones (71%) like the 
femur, humerus, and tibia, followed by flat bones (22%) such as the pelvis and skull.
84,85
  
 
Characteristic imaging features of primary bone lymphoma include involvement of a 
large portion of the affected bone, a soft tissue mass extending through an intact cortex, 
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and a permeative or moth-eaten appearance if macroscopic cortical involvement is 
present (Fig. 16).
9,12,84
 Periosteal reaction has been variably reported from none to just 
over half of cases
9,85
. A diffusely sclerotic variant is seen in only 2% of primary bone 
lymphomas, such as with the classic “ivory vertebra” appearance of an entirely sclerotic 
vertebral body
37
.  CT provides greater detail of cortical involvement, including better 
depiction of cortical integrity despite extraosseous tumor spread and moth-eaten or 
permeative destruction when present,
9,12,37
 and may also identify bony sequestra,(11-16% 
of cases).
12,85
 MR imaging is highly dependable for identifying intramedullary 
replacement, tumor extent, and extraosseous soft tissue involvement, which may be 
present without radiographic signs of cortical destruction (up to 80%) or detection of a 
soft tissue mass (up to 63% of radiographs and 20% of CTs)
85
. This pattern is also seen 
with other small round cell tumors, such as Ewing sarcoma. A distinguishing feature of 
lymphoma’s soft tissue mass is the propensity to insinuate into adjacent soft tissues and 
cross compartments without displacing or compressing structures like the neurovascular 
bundle (Fig. 16).
12
 The marrow signal characteristics are variable due to the degree of 
fibrous tissue and cellularity, but are generally low on T1 and intermediate to high on T2 
weighted sequences.
85
 The use of fat-suppression is important as these lesions may be 
similar to marrow fat on non-fat suppressed T2 images.
12
 
 
Ewing sarcoma is the third most common primary bone sarcoma (~12% of malignant 
bone tumors) and is a small round cell tumor but originates from primitive 
neuroectodermal tissue.
12,37
 These tumors, which occur in a young population (usually 
<20 years old), are highly malignant and most often occur in the pelvis (31%) or long 
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bone diaphysis (62% of peripheral skeleton). Occasional metaphyseal involvement is 
noted with very rare epiphyseal extension.
12,86
 These aggressive tumors produce a painful 
mass and may produce systemic symptoms that overlap with infection.
12,37
 
 
The characteristic radiologic imaging appearance is that of a lytic, destructive lesion with 
wide zone of transition, aggressive periosteal reaction (classically onion-skin or 
lamellated), and a large soft tissue mass.
12,30,37
 Although these lesions are most 
commonly mixed lytic and sclerotic (75%), there is no true matrix production, consistent 
with its small round cell composition.
12,86
 Uncommonly, there may be cortical thickening 
and reactive sclerosis from tumor response or saucerization of the cortex due to periosteal 
surface destruction by tumor cells and soft tissue mass-related extrinsic pressure.
12
 The 
periosteal reaction and pattern of bone destruction, including tumor margin classification, 
is best identified by CT. Frouge, et al, found that spiculated periosteal reaction and 
Codman’s triangle were the most common patterns,87 though Resnick and Kransdorf cite 
lamellated reaction as most common (57%).
88
 When aggressive, the pattern of periosteal 
reaction may be confused for osteosarcoma in the pelvis or axial skeleton.  Increased 
density from the intramedullary component may be underestimated on CT
12,86
. Thus, MR 
imaging is best to define the intramedullary extent and tumor margins as well as 
extraosseous soft tissue mass, which is often more expansive than the intramedullary 
component (Fig. 17).
37,86,87
 Because this aggressive tumor often has a large soft tissue 
component, it is of highest importance to clearly characterize involvement of surrounding 
soft tissues, including neurovascular bundles and multicompartment spread. Although the 
above described features are helpful in making the diagnosis, the MR signal 
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characteristics are not specific to the tumor, typically demonstrating inhomogeneous 
intermediate to low signal on T1 and high signal on T2 with hypocellular regions and 
areas of necrosis demonstrating lower signal on T1 and higher signal on T2.
12,37
 
Postcontrast sequences may help delineate tumor and differentiate from surrounding 
peritumoral edema.   
 
CONCLUSION 
Identifying the tumor matrix or composition, which is often more sensitive by CT and 
MR imaging as has been discussed, is helpful to accurately characterize a tumor. These 
cross sectional imaging techniques also delineate secondary features to help characterize 
lesion aggressiveness and extent. Ultimately, radiographs should always be performed 
and may make the diagnosis of a bone tumor, but CT and MR imaging are useful adjunct 
methods to help differentiate lesions when necessary, stage tumors, and guide 
management, including biopsy planning and execution. 
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FIGURE CAPTIONS 
Fig. 1. Osteoid osteoma of the humerus in an 8-year-old boy. (A) Axial CT image 
demonstrates an ovoid radiolucent cortically-based nidus (white arrow) with foci of 
central mineralization and moderate surrounding sclerosis and cortical thickening (white 
arrowheads). (B) Sagittal fat-suppressed T2 (T2FS) MR image exhibits the demarcated 
hyperintense osteoid nidus (white arrow) with extensive surrounding bone marrow 
edema. Note the normal marrow fat signal intensity in the humeral head epiphysis 
(asterisk). (C) Axial gradient echo MR image depicts the hypointense mineralization 
within the osteoid nidus (white arrow) and cortical thickening (white arrowheads). 
 
Fig. 2. Osteoblastoma of the spine (left T11 pedicle and transverse process) in a 14-year-
old girl who presented with new-onset painful scoliosis. (A) Axial CT image 
demonstrates a relatively large, well-demarcated, mildly expansile lucent lesion of the 
posterior elements of T11 with a thick sclerotic rim and mild surrounding sclerosis (black 
arrowheads).  Axial T1 precontrast (B) and T1 postcontrast (C) MR images demonstrate a 
hypointense, diffusely enhancing lesion in the left T11 pedicle and transverse process 
(white arrowheads) with surrounding reactive inflammation (black arrows, (C)). 
 
Fig. 3. Conventional osteosarcoma of the distal femur in an 8-year-old boy. (A) Sagittal 
CT image demonstrates an aggressive osteosclerotic lesion of the distal femur with 
destruction of the anterior cortex, a Codman triangle of aggressive periosteal reaction 
(white arrow), and a soft tissue mass that is non-mineralized posteriorly (open 
arrowheads) and partly mineralized anteriorly (white arrowheads).  (B) Sagittal modified 
inversion recovery (MODIR) MR image demonstrates the extraosseous soft tissue mass 
extending through the anterior and posterior cortex (open arrowheads) and surrounding 
peritumoral edema (white arrows). (C) Coronal T1 MR image demonstrates the extent of 
the intramedullary hypointense mass replacing the normal marrow fat (white arrows) and 
periosteal reaction (white arrow heads).  
 
Fig. 4. Periosteal osteosarcoma of the mid femur discovered in a 33-year-old man. (A) 
AP radiograph demonstrates a thick and irregular proximal lateral right femoral diaphysis 
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with a mineralized mass extending outward from the surface of the bone cranially (white 
arrow) and saucerization of the cortex caudally (arrowheads). Coronal fat-suppressed T1 
(T1FS) postcontrast  (B) and axial T2 (C) MR images demonstrate the hypointense signal 
of tumor mineralization (white arrow), as well as the solid, enhancing soft tissue mass 
arising from the surface of the lateral proximal femur (open arrowheads) and intraosseous 
reactive edema (black asterisk). T1 images (not shown here) demonstrated no abnormal 
marrow replacement.  
 
Fig. 5. High-grade parosteal osteosarcoma of the distal femur in a 31-year-old male. (A) 
Lateral radiograph reveals a large centrally ossified mass arising from the posterior distal 
femoral metadiaphysis (black asterisk) with a thin lucent cleft between the mass and 
cortex (black dashed arrows), a distinguishing feature of parosteal osteosarcomas. 
Scattered peripheral mineralization (white arrowheads) reveals the large size of the soft 
tissue mass, indicating a higher grade tumor. (B) Sagittal T1 MR image shows a large T1 
hypointense mass centered posterior to the distal femoral metadiaphysis with central 
hypointense ossified matrix and intramedullary extension (white asterisk). (C) Axial 
T1FS post-contrast MR image delineates the mass and soft tissue involvement, including 
sciatic nerve (black arrow) and femoral artery (white arrow) displacement and 
encasement (confirmed by operative report), as well as intramedullary extension (white 
asterisk).  
 
Fig. 6. Chondroblastoma of the proximal tibial epiphysis in a 13-year-old boy.  (A) 
Coronal CT image depicts a well-defined round lytic lesion within the proximal tibial 
epiphysis with scattered internal “ring-and-arc” chondroid matrix mineralization (white 
arrow). (B) Coronal STIR MR image demonstrates a heterogeneous intermediate-to-high 
T2 signal lesion (differing from typical high signal of cartilage due to dense immature 
cells), a thin hypointense sclerotic rim (white arrowheads), extensive surrounding bone 
marrow edema (asterisks), and periosteal edema distally along the medial proximal tibial 
metadiaphysis (white arrows). 
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Fig. 7. Chondromyxoid fibroma of the posterior iliac wing in a 29-year-old man. (A) 
Axial CT image shows a well-defined lytic lesion (white arrowheads) with slightly 
lobular contours, a sclerotic rim, and low attenuation of 30-40 HU. (B) Axial T2FS MR 
image again demonstrates the lobular lesion (white arrowheads) with hyperintense signal, 
a thin hypointense low signal rim, and no adjacent edema or extraosseous mass. This 
lesion diffusely enhanced on postcontrast images (not shown here), confirming a solid 
lesion. 
 
Fig. 8. Enchondroma of the distal femur in a 59-year-old man.  (A) Coronal CT image of 
the distal femur shows a circumscribed lytic lesion with thin peripherally calcified rim 
(white arrowhead) and internal “ring-and-arc” calcified chondroid matrix (white arrow). 
(B) Coronal STIR MR image displays a markedly hyperintense lesion with lobular 
contours (open arrowheads) and scattered internal hypointense foci (white arrow) of 
mineralized matrix, both of which are features characteristic of a chondroid lesion.  
 
Fig. 9. Low-grade chondrosarcoma of the proximal tibia in a 30-year-old woman. (A) 
Sagittal CT image demonstrates a mildly expansile lytic lesion with lobular contours, 
dense central “ring-and-arc” mineralization, and endosteal scalloping with scattered areas 
of cortical breakthrough (dashed arrows). (B) Sagittal STIR MR image also demonstrates 
the posterior proximal tibial epiphyseal/metaphyseal lesion with hyperintense signal, 
lobular contours (white arrowheads), central hypointense mineralization, and areas of 
cortical breakthrough with soft tissue mass extension (dashed arrows). 
 
Fig. 10. High-grade chondrosarcoma of the distal femur in an 83-year-old woman. (A) 
Lateral radiograph reveals an irregular poorly circumscribed lytic lesion of the distal 
femoral metadiaphysis with anterior cortical destruction (white arrowheads) and “ring-
and-arc” matrix mineralization (white arrow). (B) Sagittal T1 MR image also shows a 
large isointense intramedullary mass with central hypointense mineralization (white 
arrow) and extraosseous soft tissue extension into the prefemoral fat pad through a large 
cortical defect (white arrowheads). 
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Fig. 11. Fibrous dysplasia of the humeral diaphysis in a 9-year-old girl. (A) Sagittal CT 
image of the humerus exhibits a circumscribed, eccentric, slightly expansile 
intramedullary lytic lesion (white arrow) with internal ground-glass opacity measuring 
approximately 120 HU. Sagittal T1 (B) and T1FS post-contrast (C) MR images acquired 
7 years later demonstrate the same ovoid, eccentric, intramedullary lesion (white arrow) 
in the humeral diaphysis with isointense signal (to muscle) on T1 images and diffuse 
contrast enhancement on post-contrast images. 
 
Fig. 12. Osteofibrous dysplasia of the anterior tibial cortex in a 10-year-old girl. (A) 
Sagittal CT image exhibits an intracortical multilocular lytic lesion of the anterior 
proximal tibial diaphysis with surrounding sclerosis and thickened but intact cortex 
(white arrowheads). Sagittal STIR (B) and axial T1 (C) MR images show hyperintense 
and intermediate signal intensity, respectively, of the intracortical lytic lesions with intact 
overlying cortex (white arrowheads), sclerotic margins, and cortical thickening (open 
arrowheads). The axial image also depicts the partial width intramedullary extension with 
adjacent normal marrow fat (black asterisk). 
 
Fig. 13. Adamantinoma of the anterior tibial cortex in a 20-year-old man. (A) Lateral 
radiograph of the tibia and fibula shows a multilocular cortically-based lytic lesion with 
anterior cortical expansion (white arrows) and diffuse medullary extension. Sagittal STIR 
(B) and axial T1 (C) MR images demonstrate a somewhat aggressive lesion compared to 
the OFD of Fig. 12 with areas of anterior tibial cortical destruction and soft tissue 
extension (white arrows). Involvement of the entire axial medullary space (low signal in 
(C)), a feature more characteristic of adamantinoma than OFD, is recognized when 
compared to normal fibular marrow fat (black arrow). 
 
Fig. 14. Intraosseous lipoma of the calcaneus in a 49-year-old man.  Sagittal CT image of 
the ankle demonstrates a circumscribed lucent lesion with sclerotic margins and internal 
density equal to the subcutaneous fat or Kager’s fat pad (white star), consistent with an 
intraosseous lipoma. 
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Fig. 15. Multiple myeloma of the distal clavicle in a 68-year-old man. (A) Frontal 
radiograph of the shoulder reveals a well-defined, “punched out” lytic lesion of the distal 
clavicle (white arrowheads) with a superimposed pathologic fracture (black arrow). 
Incidentally, calcific tendinosis (dashed white arrow) is also seen. (B) Coronal STIR MR 
image shows a mildly hyperintense solid lesion of the distal clavicle with complete 
marrow replacement and bony expansion (white arrowheads). Additional 
radiographically-occult myelomatous lesions are discovered in the proximal humeral 
metadiaphysis (white arrow), which demonstrates high signal compared to the normal 
marrow fat of the humeral head. 
 
Fig. 16. Primary bone lymphoma of the proximal tibia in a 35-year-old woman. (A) Axial 
contrast enhanced CT image demonstrates ill-defined low attenuation (white arrows) in 
the muscles and soft tissues surrounding the tibial diaphysis. (B) Axial T2FS MR image 
shows the diffuse marrow signal abnormality (asterisk) of the proximal tibial diaphysis 
with intact cortex and a large surrounding soft tissue mass (white arrows) that involves all 
of the muscle compartments of the calf, extends into the pretibial subcutaneous tissues, 
and encases the posterior tibial artery (white arrowhead) without displacement or 
compression. (C) Coronal T1 MR image delineates the extent of low signal marrow 
replacement spanning nearly the entire proximal two thirds of the tibia. 
 
Fig. 17. Ewing sarcoma of the fibula in a 17-year-old girl. (A) Axial contrast enhanced 
CT image of the proximal calf shows an ill-defined low attenuation mass (white arrows) 
involving the anterior and deep posterior compartments of the proximal calf. (B) Axial 
STIR MR image more clearly depicts a hyperintense soft tissue mass (white arrows) 
centered around the proximal fibula, involving multiple muscle compartments, as well as 
diffuse bone marrow signal abnormality of the proximal fibula (dashed arrow). 
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